BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hölscher C. Evidence for pathophysiological commonalities between metabolic and neurodegenerative diseases. Int Rev Neurobiol 2020;155:65-89. [PMID: 32854859 DOI: 10.1016/bs.irn.2020.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kubis-Kubiak A, Wiatrak B, Piwowar A. The Impact of High Glucose or Insulin Exposure on S100B Protein Levels, Oxidative and Nitrosative Stress and DNA Damage in Neuron-Like Cells. Int J Mol Sci 2021;22:5526. [PMID: 34073816 DOI: 10.3390/ijms22115526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ostrakhovitch EA, Song ES, Macedo JKA, Gentry MS, Quintero JE, van Horne C, Yamasaki TR. Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor. Neurosci Lett 2021;:136428. [PMID: 34971771 DOI: 10.1016/j.neulet.2021.136428] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Willmann C, Brockmann K, Wagner R, Kullmann S, Preissl H, Schnauder G, Maetzler W, Gasser T, Berg D, Eschweiler GW, Metzger F, Fallgatter AJ, Häring HU, Fritsche A, Heni M. Insulin sensitivity predicts cognitive decline in individuals with prediabetes. BMJ Open Diabetes Res Care 2020;8:e001741. [PMID: 33203727 DOI: 10.1136/bmjdrc-2020-001741] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yang X, Feng P, Ji R, Ren Y, Wei W, Hölscher C. Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease. Expert Opin Ther Targets 2022. [PMID: 35584372 DOI: 10.1080/14728222.2022.2079492] [Reference Citation Analysis]